Futura Medical

Futura's innovation strategy applies advanced science to develop products with compelling commercial potential using our advanced proprietary transdermal technology. Based in Surrey, UK, the company's shares trade on the AIM market of the London Stock Exchange. Futura's development pipeline focuses on sexual healthcare and pain relief management and we are evaluating further therapeutic opportunities as potential additions to the pipeline. Futura is gaining recognition within the pharmaceutical industry for its strengths in transdermal drug delivery technology. We have a number of relationships with key players.
Type
Public
HQ
Guildford, GB
Founded
1997
Employees
8 (est)+60%
Futura Medical was founded in 1997 and is headquartered in Guildford, GB

Key People at Futura Medical

James Barder

James Barder

CEO
Bill Potter

Bill Potter

CSO

Futura Medical Locations

Guildford, GB

Futura Medical Metrics

Futura Medical Summary

Market capitalization

£58.7 M

Closing share price

£0.603
Futura Medical's current market capitalization is £58.7 M.

Futura Medical Financials

We estimate that Futura Medical's revenue is £29.5 K in FY, 2015 which is 32.9% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

£371 K£43.9 K£29.5 K

Revenue growth, %

-88.2%-32.9%

    Futura Medical Market Value History

    Futura Medical Online Presence

    Futura Medical News

    Futura Medical Company Life

    You may also be interested in